Rufinamide up to 45 milligram per kilogram per day (mg/kg/day).
- Participants who were on rufinamide treatment and have completed Study E2080-G000-303 in Poland.
- Participants were randomized to the other antiepileptic drug (AED) treatment group in study E2080-G000-303.
Eisai Medical Information
Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.